✦ LIBER ✦

Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump

✍ Scribed by Bruno Damascelli; A. Marchianò; C. Spreafico; R. Lutman; M. Salvetti; M. G. Bonalumi; M. Mauri; F. Garbagnati; A. Del Nero; G. Comeri; G. Conti; S. Coppoli; G. Benetti; P. Tralongo; D. Belussi

Publisher: John Wiley and Sons
Year: 1990
Tongue: English
Weight: 539 KB
Volume: 66
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19900715)66:2<237::aid-cncr2820660207>3.0.co;2-f

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Simplified chronomodulated continuous in

Simplified chronomodulated continuous infusion of floxuridine in patients with metastatic renal cell carcinoma

✍ Thierry Conroy; Lionnel Geoffrois; Francois Guillemin; Elisabeth Luporsi; Ivan K 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 776 KB

Continuous intrahepatic infusion of flox

Continuous intrahepatic infusion of floxuridine and leucovorin through an implantable pump for the treatment of hepatic metastases from colorectal carcinoma

✍ Nancy Kemeny; Alfred Cohen; Joseph R. Bertino; Elin R. Sigurdson; Jose Botet; Pa 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

Neoadjuvant chemotherapy with cytosine a

Neoadjuvant chemotherapy with cytosine arabinoside by continuous infusion and cisplatin for resectable squamous cell carcinoma of the esophagus

✍ Dr. Marc Trudeau; Gerald Batist; Michael Thirlwell; Gerald Boos; Hanni Shennib; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

## Abstract The combination of cisplatin and cytosine arabinoside has been shown in experimental models to be synergistic. We conducted a pilot study of cytosine arabinoside and cisplatin in unresectable or metastatic cancer of the esophagus in five patients and found significant activity, also on

Phase II trial of 5-fluorouracil, interf

Phase II trial of 5-fluorouracil, interferon-α and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma

✍ Julie A. Ellerhorst; Avishay Sella; Robert J. Amato; Shi-Ming Tu; Randall E. Mil 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## RESULTS. Fifty-five patients were enrolled in the trial and 52 were evaluable for ogy, The University of Texas M. D. Anderson response. All patients experienced fever and flu-like symptoms. Grade 3 or 4 nonhe-Cancer Center, Houston, Texas. matologic toxic effects included hypertension (48%), d

A phase II trial of interleukin-2 by con

A phase II trial of interleukin-2 by continuous infusion and interferon by intramuscular injection in patients with renal cell carcinoma

✍ A. Mittelman; C. Puccio; T. Ahmed; J. Zeffren; A. Choudhury; Z. Arlin 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB 👁 2 views

Evaluation of low dose continuous infusi

Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma. A Southwest Oncology Group study

✍ Julie A. Kish; Michael Wolf; E. David Crawford; Joseph T. Leimert; Anton Buesche 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

Background. The response rate of metastatic renal cell cancer to cytotoxic therapy over the last 10 years has been 5.6%. Low dose continuous 5-fluorouracil(5-FU) has demonstrated efficacy in other cytotoxic refractory tumors, such as pancreas, colorectal, and recurrent breast. The Southwest Oncology